Home › Funds › Calamos Advisors LLC › ABBV

Calamos Advisors LLC position in ABBV

ABBVIE INC · Health Care

Calamos Advisors LLC reported holding 406,639 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$106.4M, representing 0.57% of its reported portfolio and ranking #37 among its reported holdings. Calamos Advisors LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)406.64K sh
Reported value held$106.37M
Portfolio Weight0.57%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Calamos Advisors LLC's ABBV position evolved

Calamos Advisors LLC first disclosed a stake in ABBV in Q3 2023 at 472,386 shares (US$70.4M). The position peaked in Q4 2025 at 466,290 shares, worth US$106.5M. Across 13 filings, Calamos Advisors LLC increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 406,639 shares valued at US$106.4M — an increase of 6,746 shares quarter over quarter.. Notable position changes include a 96% trim in Q2 2025 (shares rose 26% over the following quarter), a 2110% increase in Q3 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 472.39K $70.41M New
Q4 2023 468.47K $72.60M Reduce
Q1 2024 460.61K $83.88M Reduce
Q2 2024 449.50K $77.10M Reduce
Q3 2024 442.77K $87.44M Reduce
Q4 2024 443.29K $78.77M Hold
Q1 2025 501.76K $105.13M Add
Q2 2025 20.40K $4.27M Reduce
Q3 2025 450.83K $104.39M Add
Q4 2025 466.29K $106.54M Add
Q1 2026 483.67K $105.19M Add
Q2 2026 399.89K $100.63M Reduce
Q3 2026 406.64K $106.37M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Calamos Advisors LLC held ABBV?

Calamos Advisors LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Calamos Advisors LLC's current position in ABBV?

As of Q3 2026, Calamos Advisors LLC holds 406.64K shares of ABBV (ABBVIE INC), valued at $106.37M, representing 0.57% of its reported portfolio and ranking #37.

Has Calamos Advisors LLC been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Calamos Advisors LLC increased its position in ABBV. The position peaked in Q4 2025 at 466.29K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.